| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047457283 |
| P356 | DOI | 10.1016/S0893-133X(99)00148-7 |
| P698 | PubMed publication ID | 10731626 |
| P2093 | author name string | F X Vollenweider | |
| C Baumann | |||
| A Gamma | |||
| M E Liechti | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | MDMA | Q69488 |
| serotonin | Q167934 | ||
| altered state of consciousness | Q852859 | ||
| P304 | page(s) | 513-521 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Neuropsychopharmacology | Q2261280 |
| P1476 | title | Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram | |
| P478 | volume | 22 |
| Q47777762 | (±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA. |
| Q92575706 | 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors |
| Q34565712 | 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings |
| Q38829190 | 3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner. |
| Q34190116 | A Clinical Plan for MDMA (Ecstasy) in the Treatment of Posttraumatic Stress Disorder (PTSD): Partnering with the FDA |
| Q64070251 | A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy |
| Q36209977 | A brief overview of the clinical pharmacology of "club drugs". |
| Q36397237 | A clinical crossroads for MDMA. |
| Q34476901 | A comprehensive review of MDMA and GHB: two common club drugs |
| Q84576557 | A perhaps unexpected role of norepinephrine in actions of MDMA |
| Q48381656 | A prospective cohort study on sustained effects of low-dose ecstasy use on the brain in new ecstasy users |
| Q36410788 | A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers |
| Q35105559 | Acute Psychological and Neurophysiological Effects of MDMA in Humans |
| Q33907331 | Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans |
| Q44610477 | Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users |
| Q38962662 | Altered Insula Connectivity under MDMA. |
| Q46058170 | An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users |
| Q44588974 | Angry cognitive bias, trait aggression and impulsivity in substance users |
| Q44127507 | Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users |
| Q46477520 | Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users |
| Q58088980 | Behavioral Psychopharmacology of MDMA and MDMA-Like Drugs: A Review of Human and Animal Studies |
| Q35142554 | Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat |
| Q30473430 | Brain mechanisms of hallucinogens and entactogens |
| Q41669953 | Changes in serotonin transporter (5-HTT) gene expression in peripheral blood cells after MDMA intake. |
| Q28243881 | Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices |
| Q24633299 | Club drugs: review of the 'rave' with a note of concern for the Indian scenario |
| Q41595301 | Comparative Effects of Methylphenidate, Modafinil, and MDMA on Response Inhibition Neural Networks in Healthy Subjects. |
| Q40594777 | Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. |
| Q57176236 | Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine |
| Q34030711 | Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study |
| Q47551565 | Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter |
| Q35965775 | Differences in the locomotor-activating effects of indirect serotonin agonists in habituated and non-habituated rats |
| Q37416406 | Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice |
| Q91305817 | Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects |
| Q28483370 | Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study |
| Q24620135 | Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study |
| Q58419076 | Ecstasy and sleep disturbance: Progress towards elucidating a role for the circadian system |
| Q27329826 | Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis) |
| Q50574947 | Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex. |
| Q35107898 | Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters |
| Q64217983 | Effects of MDMA on attention to positive social cues and pleasantness of affective touch |
| Q37226598 | Effects of MDMA on body temperature in humans |
| Q28727300 | Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors |
| Q45936086 | Equivalent effects of acute tryptophan depletion on REM sleep in ecstasy users and controls. |
| Q34235666 | Genetic deletion of trace amine 1 receptors reveals their role in auto-inhibiting the actions of ecstasy (MDMA). |
| Q34558846 | How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? |
| Q50549548 | Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart. |
| Q46857178 | Initial deficit and recovery of function after MDMA preexposure in rats |
| Q39703486 | Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells. |
| Q43842107 | Investigation of serotonin-1A receptor function in the human psychopharmacology of MDMA. |
| Q24630561 | Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others |
| Q47206849 | Key interindividual determinants in MDMA pharmacodynamics. |
| Q42659793 | Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA). |
| Q40362823 | MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment. |
| Q43842077 | MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task |
| Q50592804 | MDMA enhances "mind reading" of positive emotions and impairs "mind reading" of negative emotions. |
| Q48095503 | MDMA induces EPSP-Spike potentiation in rat ventral hippocampus in vitro via serotonin and noradrenaline release and coactivation of 5-HT4 and beta1 receptors |
| Q42465875 | MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro |
| Q40007746 | MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor. |
| Q73371204 | Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms |
| Q55043421 | Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation. |
| Q35877150 | Monoamine transporters: vulnerable and vital doorkeepers |
| Q24619949 | Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA) |
| Q36797987 | Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms |
| Q44959633 | Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination |
| Q38048826 | Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions. |
| Q28273207 | Pharmacological characterization of designer cathinones in vitro |
| Q22305514 | Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review |
| Q34647657 | Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk |
| Q28210514 | Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP |
| Q24629918 | Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys |
| Q34564778 | Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. |
| Q34353067 | Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram |
| Q34150103 | Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain |
| Q30946517 | Role of serotonin via 5-HT2B receptors in the reinforcing effects of MDMA in mice |
| Q47662199 | Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice |
| Q33652473 | Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats |
| Q52286391 | Substance Use Disorders and Neurologic Illness. |
| Q36852402 | The Effects of 4-Methylethcathinone on Conditioned Place Preference, Locomotor Sensitization, and Anxiety-Like Behavior: A Comparison with Methamphetamine. |
| Q47141840 | The Mediating Role of A2A Adenosine Receptors in the Mitochondrial Pathway of Apoptotic Hippocampal Cell Death, Following the Administration of MDMA in Rat. |
| Q30341737 | The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA). |
| Q34502080 | The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder |
| Q43238229 | The Role of The A2A Receptor in Cell Apoptosis Caused by MDMA. |
| Q34830911 | The effects and consequences of selected club drugs |
| Q38937390 | The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants? |
| Q50921579 | The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. |
| Q38376332 | The influence of 5-HTT and COMT genotypes on verbal fluency in ecstasy users |
| Q35754068 | The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study |
| Q28240897 | The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans |
| Q28361466 | The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs |
| Q34495787 | The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals. |
| Q35607083 | The role of MDMA (Ecstasy) in coping with negative life situations among urban young adults |
| Q24606265 | The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study |
| Q51971591 | The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers. |
| Q22252794 | Toxicity of amphetamines: an update |
| Q54297002 | Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. |
Search more.